Search

everythinglearnresearchcommunity

for

Search:↓

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.

Androgens play a key role in causing alopecia by changing the hair growth cycle.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Finasteride helps reduce lung inflammation and damage after trauma and infection.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Long COVID causes lasting symptoms and needs ongoing care.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

A blood pressure drug, diltiazem, may also help treat influenza.

Extra virgin olive oil may boost the immune system and help fight infections like COVID-19.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

New therapies are being developed that target integrin pathways to treat various diseases.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Managing severe infections in SLE patients requires tailored treatment strategies.

Non-Kuwaitis with COVID-19 had higher chances of severe outcomes than Kuwaitis.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Patients who survive critical illness often face long-lasting physical, mental, and cognitive issues, with many unable to return to work within a year.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Anabolic steroid users may face higher risk of severe COVID-19.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.